Micromet prices public offering at $7.00 per share

NewsGuard 100/100 Score

Micromet, Inc. (Nasdaq: MITI) announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share.  The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company.  All of the shares in the offering are being sold by Micromet.  The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.

The Company expects to receive net proceeds from the offering, after underwriting discount and offering expenses payable by the Company, of approximately $65.5 million (prior to any exercise of the Underwriters' option to purchase additional shares of common stock). The Company plans to use the net proceeds from the financing primarily for general corporate purposes, which may include research and development, capital expenditures, working capital and general and administrative expenses.

Goldman, Sachs & Co. is acting as sole book-running manager for this offering. Piper Jaffray & Co., RBC Capital Markets Corporation, Needham & Company, LLC, ROTH Capital Partners, LLC, Ladenburg Thalmann & Co. Inc., and Maxim Group LLC are acting as co- managers. The offering of these securities will be made only by means of a prospectus, copies of which may be obtained from Goldman, Sachs & Company, Attn: Prospectus Department, 85 Broad Street, New York, New York 10004, Telephone 1-866-471-2526, or by email at [email protected]

The shares will be offered and sold pursuant to a shelf registration statement filed with the Securities and Exchange Commission on October 16, 2009 and declared effective on November 2, 2009.

SOURCE Micromet, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.